T

Tecon Biology Co Ltd
SZSE:002100

Watchlist Manager
Tecon Biology Co Ltd
SZSE:002100
Watchlist
Price: 7.17 CNY 3.31% Market Closed
Market Cap: 9.8B CNY
Have any thoughts about
Tecon Biology Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Tecon Biology Co Ltd

Current Assets 8.9B
Cash & Short-Term Investments 2.7B
Receivables 1.4B
Other Current Assets 4.8B
Non-Current Assets 7.8B
Long-Term Investments 33.8m
PP&E 7.1B
Intangibles 564.9m
Other Non-Current Assets 96.2m
Current Liabilities 6.4B
Accounts Payable 556.7m
Accrued Liabilities 244.9m
Short-Term Debt 3B
Other Current Liabilities 2.5B
Non-Current Liabilities 3.7B
Long-Term Debt 2B
Other Non-Current Liabilities 1.7B

Balance Sheet
Tecon Biology Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
625
732
848
1 696
1 979
1 858
1 950
3 312
3 201
2 673
Cash
1
1
24
1
2
0
0
3 312
3 201
2 673
Cash Equivalents
624
731
824
1 695
1 977
1 858
1 950
0
0
0
Short-Term Investments
5
14
38
29
14
87
20
0
650
0
Total Receivables
235
287
232
287
696
740
909
1 136
1 240
1 179
Accounts Receivables
103
140
158
197
215
314
320
306
396
421
Other Receivables
132
147
74
90
481
426
589
830
844
758
Inventory
935
772
893
901
2 502
3 097
6 020
5 251
6 039
4 554
Other Current Assets
231
261
529
662
667
913
1 797
913
1 282
555
Total Current Assets
2 031
2 066
2 541
3 575
5 858
6 694
10 697
10 612
12 412
8 961
PP&E Net
1 533
1 490
1 693
2 010
2 346
4 029
4 562
6 082
6 492
7 103
PP&E Gross
1 533
1 490
1 693
2 010
2 346
4 029
4 562
6 082
6 492
7 103
Accumulated Depreciation
527
642
737
879
1 034
1 313
1 650
2 143
2 726
3 363
Intangible Assets
204
176
174
189
191
265
260
272
275
368
Goodwill
22
0
0
0
0
0
0
22
22
178
Long-Term Investments
2
56
52
44
51
81
105
108
105
36
Other Long-Term Assets
19
17
30
54
63
85
106
42
54
105
Other Assets
22
0
0
0
0
0
0
22
22
178
Total Assets
3 811
N/A
3 805
0%
4 491
+18%
5 873
+31%
8 509
+45%
11 154
+31%
15 729
+41%
17 139
+9%
19 361
+13%
16 752
-13%
Liabilities
Accounts Payable
204
152
152
159
197
251
422
465
627
692
Accrued Liabilities
84
69
138
141
113
240
565
417
377
351
Short-Term Debt
797
619
840
859
2 680
2 825
5 167
4 422
3 734
3 819
Current Portion of Long-Term Debt
11
0
0
0
0
400
327
742
727
1 488
Other Current Liabilities
372
428
527
604
557
585
891
926
709
738
Total Current Liabilities
1 468
1 269
1 657
1 763
3 547
4 301
7 372
6 971
6 174
7 087
Long-Term Debt
19
0
0
936
1 576
1 586
1 399
2 353
3 436
1 588
Deferred Income Tax
2
1
0
0
0
0
0
1
1
18
Minority Interest
35
33
75
69
69
572
634
635
1 715
1 504
Other Liabilities
139
151
129
118
107
102
90
81
86
143
Total Liabilities
1 662
N/A
1 453
-13%
1 862
+28%
2 887
+55%
5 299
+84%
6 562
+24%
9 496
+45%
10 041
+6%
11 411
+14%
10 341
-9%
Equity
Common Stock
434
963
963
963
963
1 066
1 075
1 354
1 354
1 365
Retained Earnings
621
824
1 100
1 411
1 629
2 173
3 681
2 447
2 748
1 052
Additional Paid In Capital
1 094
565
565
566
577
1 376
1 473
3 303
3 842
3 942
Treasury Stock
0
0
0
0
5
30
0
0
0
0
Other Equity
0
0
0
45
45
8
4
5
5
51
Total Equity
2 149
N/A
2 352
+9%
2 629
+12%
2 986
+14%
3 210
+8%
4 593
+43%
6 233
+36%
7 098
+14%
7 950
+12%
6 411
-19%
Total Liabilities & Equity
3 811
N/A
3 805
0%
4 491
+18%
5 873
+31%
8 509
+45%
11 154
+31%
15 729
+41%
17 139
+9%
19 361
+13%
16 752
-13%
Shares Outstanding
Common Shares Outstanding
868
963
963
963
959
1 059
1 075
1 354
1 354
1 365

See Also

Discover More